Literature DB >> 17875529

t(6;14)(q15;q32) in a patient with CD5+CD10+ diffuse large B-cell lymphoma.

Miyuki Hayama1, Nozomi Niitsu, Masaaki Higashihara, Hirokazu Nakamine, Ikuo Miura.   

Abstract

A 68-year-old man presented with systemic lymph node swelling. A biopsy specimen taken from the right cervical lymph node showed that the normal architecture was replaced by a diffuse proliferation of large lymphoid cells with large atypical nuclei. Immunohistochemical analysis showed that the atypical lymphoid cells were positive for CD5, CD10, CD20, CD79a, and Bcl2, and negative for CD3 and cyclin D1. A diagnosis of diffuse large B-cell lymphoma was made. Karyotypic findings included add(5)(q13), del(6)(q13), add(17)(p11), add(19)(p11), add(19)(p13), and t(6;14)(q15;q32). The serum lactate dehydrogenase level and indirect bilirubin level were slightly elevated. Elliptocytosis was observed in the peripheral blood, and a diagnosis of hereditary spherocytosis was made from the family history. Regarding CD5+CD10+ diffuse large B-cell lymphoma with a non-random chromosomal translocation of t(6;14)(q15;q32), studies on the mechanism of lymphomagenesis are needed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17875529     DOI: 10.1532/IJH97.07022

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  17 in total

1.  Activation of Maf/AP-1 repressor Bach2 by oxidative stress promotes apoptosis and its interaction with promyelocytic leukemia nuclear bodies.

Authors:  Akihiko Muto; Satoshi Tashiro; Haruka Tsuchiya; Akihiro Kume; Masamoto Kanno; Etsuro Ito; Masayuki Yamamoto; Kazuhiko Igarashi
Journal:  J Biol Chem       Date:  2002-03-28       Impact factor: 5.157

2.  Translocation (6;14) in childhood acute mixed lineage leukemia.

Authors:  S Q Wu; J Kuo; X R Chen; S A Chen; J J Quinn
Journal:  Cancer Genet Cytogenet       Date:  2003-03

3.  Genome-wide array-based comparative genomic hybridization of diffuse large B-cell lymphoma: comparison between CD5-positive and CD5-negative cases.

Authors:  Hiroyuki Tagawa; Shinobu Tsuzuki; Ritsuro Suzuki; Sivasundaram Karnan; Akinobu Ota; Yoshihiro Kameoka; Miyuki Suguro; Keitaro Matsuo; Motoko Yamaguchi; Masataka Okamoto; Yasuo Morishima; Shigeo Nakamura; Masao Seto
Journal:  Cancer Res       Date:  2004-09-01       Impact factor: 12.701

4.  De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients.

Authors:  Motoko Yamaguchi; Masao Seto; Masataka Okamoto; Ryo Ichinohasama; Naoya Nakamura; Tadashi Yoshino; Junji Suzumiya; Takuhei Murase; Ikuo Miura; Takashi Akasaka; Jun-ichi Tamaru; Ritsuro Suzuki; Yoshitoyo Kagami; Masami Hirano; Yasuo Morishima; Ryuzo Ueda; Hiroshi Shiku; Shigeo Nakamura
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

5.  Prognostic significance of BACH2 expression in diffuse large B-cell lymphoma: a study of the Osaka Lymphoma Study Group.

Authors:  Emiko Sakane-Ishikawa; Shin-Ichi Nakatsuka; Yasuhiko Tomita; Shigeki Fujita; Itsuko Nakamichi; Tetsuya Takakuwa; Haruo Sugiyama; Shirou Fukuhara; Masayuki Hino; Akihisa Kanamaru; Toshihiro Soma; Machiko Tsukaguchi; Kazuhiko Igarashi; Yuzuru Kanakura; Katsuyuki Aozasa
Journal:  J Clin Oncol       Date:  2005-11-01       Impact factor: 44.544

6.  The BTB/POZ domain: a new protein-protein interaction motif common to DNA- and actin-binding proteins.

Authors:  O Albagli; P Dhordain; C Deweindt; G Lecocq; D Leprince
Journal:  Cell Growth Differ       Date:  1995-09

7.  The chromosome changes in non-Burkitt lymphomas.

Authors:  B R Reeves; V L Pickup
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

8.  B-cell lymphomas with coexpression of CD5 and CD10.

Authors:  Henry Y Dong; Wojciech Gorczyca; Zach Liu; Patricia Tsang; C Daniel Wu; Patti Cohen; James Weisberger
Journal:  Am J Clin Pathol       Date:  2003-02       Impact factor: 2.493

9.  Cytogenetic features of de novo CD5-positive diffuse large B-cell lymphoma: chromosome aberrations affecting 8p21 and 11q13 constitute major subgroups with different overall survival.

Authors:  Tomoko Yoshioka; Ikuo Miura; Masaaki Kume; Naoto Takahashi; Masataka Okamoto; Ryo Ichinohasama; Tadashi Yoshino; Motoko Yamaguchi; Makoto Hirokawa; Ken-Ichi Sawada; Shigeo Nakamura
Journal:  Genes Chromosomes Cancer       Date:  2005-02       Impact factor: 5.006

Review 10.  Monoclonal antibody therapy for B-cell lymphoma.

Authors:  Antonio J Grillo-López
Journal:  Int J Hematol       Date:  2002-12       Impact factor: 2.319

View more
  3 in total

1.  Establishment of CD5 and CD10 double-positive mature B-cell line, WILL1, showing complex 8q24 translocation involving 14q32 and 6q27.

Authors:  Shima Uneda; Minako Gotoh; Takashi Sonoki; Kazuhiro Nishida; Yasushi Nakamura; Miwa Kurimoto; Nobuyoshi Hanaoka; Hiroshi Matsuoka; Masafumi Taniwaki; Hideki Nakakuma
Journal:  Int J Hematol       Date:  2008-10-30       Impact factor: 2.490

2.  Aggressive CD5-positive B-cell lymphoma after remission of CD5-negative follicular lymphoma with distinct immunoglobulin heavy chain rearrangement and translocation.

Authors:  Takashi Sonoki; Sonoko Ishihara; Shima Uneda; Nobuyoshi Hanaoka; Miwa Kurimoto; Hiroshi Matsuoka; Hideki Nakakuma
Journal:  Int J Hematol       Date:  2008-08-30       Impact factor: 2.490

Review 3.  Paraspinal extramedullary hematopoiesis in hereditary spherocytosis with a concurrent follicular lymphoma: case report and review of the literature.

Authors:  Ricardo Molina-Urra; Daniel Martinez; Amaia Sagasta; Ana Carrio; Xavier Setoain; Benet Nomdedeu; Elias Campo
Journal:  Diagn Pathol       Date:  2015-09-15       Impact factor: 2.644

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.